Cargando…

Metastatic Fibrolamellar Hepatocellular Carcinoma to the Pancreas

Fibrolamellar hepatocellular carcinoma (FL-HCC) is a rare variant of hepatocellular carcinoma, usually presenting in the younger population (<40 years) without underlying liver disease. Although it has a better prognosis than hepatocellular carcinoma, it has a high rate of recurrence months to ye...

Descripción completa

Detalles Bibliográficos
Autores principales: Villa, Nicolas A., Pannala, Rahul, Faigel, Douglas O., Haakinson, Danielle J., Katariya, Nitin, Ramanathan, Ramesh, Jaroszewski, Dawn, Lidner, Thomas K., Byrne, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560303/
https://www.ncbi.nlm.nih.gov/pubmed/26351415
http://dx.doi.org/10.1159/000437290
Descripción
Sumario:Fibrolamellar hepatocellular carcinoma (FL-HCC) is a rare variant of hepatocellular carcinoma, usually presenting in the younger population (<40 years) without underlying liver disease. Although it has a better prognosis than hepatocellular carcinoma, it has a high rate of recurrence months to years after primary resection. While sites of recurrence usually involve the liver, regional lymph nodes, peritoneum, and lung, metastasis to the pancreas is extremely rare, with only 2 other cases reported in the literature. We present the case of a 46-year-old patient with metastatic FL-HCC to the pancreas 30 years after diagnosis and 26 years since his last resected liver recurrence.